Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0476089 (
endometrial cancer
)
11,379
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Objectives Patients with cervical cancer have lower bone mass than women without cancer, whereas women with
endometrial cancer
have higher bone mineral density (BMD) than control subjects, possibly due to the prevalence of high body-fat mass. The aim of this study was to compare BMD in patients with cervical cancer,
endometrial cancer
and controls. Methods We analyzed and compared spinal and femoral BMD in 130 patients with cervical cancer, 68 with
endometrial cancer
, and 140 age-matched menopausal female control subjects. We also compared serum calcium, phosphorus, total alkaline phosphatase, osteocalcin, and urinary deoxypyridinoline levels. Results Compared with the control group, T-scores for some lumbar vertebrae (L4), the femoral neck, and Ward's triangle were lower in patients with cervical cancer, whereas only L4 T-scores were significantly lower in patients with
endometrial cancer
.
Deoxypyridinoline
levels were significantly lower in women with
endometrial cancer
(p < 0.002) than in women with cervical cancer, but no other biochemical variables differed among groups. Conclusions Cervical cancer was associated with lower BMD, especially in femoral BMD, and may be a risk factor for secondary osteoporosis. However,
endometrial cancer
generally seemed to have no damaging effect on bone except at L4. A further larger follow-up study in more populations is required to clarify these findings.
...
PMID:RETRACTED: Different bone mineral density in cervical and endometrial cancer. 2447 86